iNet Login|
United States
Pharma & Biopharma Manufacturing & Testing Services
Contact Us 1.800.756.5658

BioReliance announced today that it is expanding its Genetic Toxicology operations by adding two experienced scientists in this area. This expansion includes the additions of Dr. Leon F. Stankowski, Jr. and Dr. Shambhu Roy.

03/03/2011

ROCKVILLE, MD – March 3, 2011 --

BioReliance announced today that it is expanding its Genetic Toxicology operations by adding two experienced scientists in this area. This expansion includes the additions of Dr. Leon F. Stankowski, Jr. and Dr. Shambhu Roy.

BioReliance Corporation is a leading contract services company in the area of product safety. Its clients include pharmaceutical, biotechnology, chemical, consumer product, medical device and academic organizations.

Dr. Stankowski joins BioReliance as a Principal Scientist and Program Consultant for Genetic Toxicology. Dr. Stankowski received his PhD in Biomedical Sciences (Genetics) from the University of Tennessee-Oak Ridge. Since 1984 he has worked in the field of Genetic Toxicology for both Pharmaceutical and contract services companies and is globally recognized in the field. He will serve BioReliance as both a study director and as principal scientific support for clients requiring advice on program design.

Dr. Roy has been named Senior Scientist in the Genetic Toxicology Department. Dr. Roy will serve as study director and have overall scientific oversight of the In Vitro Cytogenetics laboratory of the Toxicology division. Dr. Roy has over 20 years experience in Genetic Toxicology and received his PhD from Gujarat University in Ahmedabad, India. Dr. Roy was a post-doctoral research fellow with Dr. David Eastmond (UC Riverside), and has spent his career in contract service organizations. “I am delighted that these talented scientists are able to join our team at BioReliance,” said President and CEO, Charles C. Harwood, Jr. “The additions of Dr. Stankowski and Dr. Roy, along with the recent addition of Dr. Marilyn Aardema as Chief Scientific Officer for Toxicology, will serve to ensure that BioReliance moves forward as the leader in the field of Genetic Toxicology.”


About BioReliance

BioReliance Corporation is a leading provider of cost-effective contract services, offering more than 1,000 tests or services related to biologics safety testing, specialized toxicology and animal health diagnostics. Founded in 1947, BioReliance is headquartered in Rockville, Maryland, with laboratory operations in Rockville and Scotland and offices in Tokyo, Japan, and Bangalore, India. The Company employs more than 600 people globally. For more information, visit www.bioreliance.com.


# # #

Apps, Tools, Newsletters & More...
  Find the latest scientific resources from Sigma-Aldrich.

Copyright © 2017 Sigma-Aldrich Co. LLC.  All Rights Reserved. Reproduction of any materials from the site is strictly forbidden without permission.  Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich Co. LLC. Sigma-Aldrich Corp. is a subsidiary of Merck KGaA, Darmstadt, Germany  Terms | Privacy